A phase II study of LFP therapy (5-FU (5-fluorourasil) continuous infusion (CVI) and Low-dose consecutive (Cisplatin) CDDP) in advanced biliary tract carcinoma

Por Kobayashi, Kazuma, Tsuji, Akihito, Morita, Sojiro, Horimi, Tadashi, Shirasaka, Tetsuhiko, Kanematsu, Takashi
Publicado em 2006

Randomized phase II study of cetuximab versus irinotecan and cetuximab in patients with chemo-refractory KRAS codon G13D metastatic colorectal cancer (G13D-study)

Por Nakamura, Masato, Aoyama, Toru, Ishibashi, Keiichiro, Tsuji, Akihito, Takinishi, Yasutaka, Shindo, Yoshiaki, Sakamoto, Junichi, Oba, Koji, Mishima, Hideyuki
Publicado no Cancer Chemother Pharmacol (2016)

Phase II trial of nanoparticle albumin-bound paclitaxel as second-line chemotherapy for unresectable or recurrent gastric cancer

Por Sasaki, Yasutsuna, Nishina, Tomohiro, Yasui, Hirofumi, Goto, Masahiro, Muro, Kei, Tsuji, Akihito, Koizumi, Wasaburo, Toh, Yasushi, Hara, Takuo, Miyata, Yoshinori
Publicado no Cancer Sci (2014)

Observational cohort study focused on treatment continuity of patients administered XELOX plus bevacizumab for previously untreated metastatic colorectal cancer

Por Kotaka, Masahito, Ikeda, Fusao, Tsujie, Masaki, Yoshioka, Shinichi, Nakamoto, Yoshihiko, Ishii, Takaaki, Kyogoku, Takahisa, Kato, Takeshi, Tsuji, Akihito, Kobayashi, Michiya
Publicado no Onco Targets Ther (2016)

The combination of HLA-B*15:01 and DRB1*15:01 is associated with gemcitabine plus erlotinib-induced interstitial lung disease in patients with advanced pancreatic cancer

Por Nishimura, Meiko, Toyoda, Masanori, Takenaka, Kei, Imamura, Yoshinori, Chayahara, Naoko, Kiyota, Naomi, Mukohara, Toru, Kotake, Takeshi, Tsuji, Akihito, Saito, Kosuke, Saito, Yoshiro, Minami, Hironobu
Publicado no Cancer Chemother Pharmacol (2016)

Feasibility of sequential adjuvant chemotherapy with a 3-month oxaliplatin-based regimen followed by 3 months of capecitabine in patients with stage III and high-risk stage II colo...

Por Tsuruta, Atsushi, Yamashita, Kazuki, Tanioka, Hiroaki, Tsuji, Akihito, Inukai, Michio, Yamakawa, Toshiki, Yamatsuji, Tomoki, Yoshimitsu, Masanori, Toyota, Kazuhiro, Yamano, Taketoshi, Nagasaka, Takeshi, Okajima, Masazumi
Publicado no Drug Des Devel Ther (2016)

Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations

Por Yoshino, Takayuki, Komatsu, Yoshito, Yamada, Yasuhide, Yamazaki, Kentaro, Tsuji, Akihito, Ura, Takashi, Grothey, Axel, Van Cutsem, Eric, Wagner, Andrea, Cihon, Frank, Hamada, Yoko, Ohtsu, Atsushi
Publicado no Invest New Drugs (2014)

Determination of Prognostic Factors in Japanese Patients With Advanced Gastric Cancer Using the Data From a Randomized Controlled Trial, Japan Clinical Oncology Group 9912

Por Takahari, Daisuke, Boku, Narikazu, Mizusawa, Junki, Takashima, Atsuo, Yamada, Yasuhide, Yoshino, Takayuki, Yamazaki, Kentaro, Koizumi, Wasaburo, Fukase, Kazutoshi, Yamaguchi, Kensei, Goto, Masahiro, Nishina, Tomohiro, Tamura, Takao, Tsuji, Akihito, Ohtsu, Atsushi
Publicado em 2014

Phase II trial of capecitabine plus modified cisplatin (mXP) as first-line therapy in Japanese patients with metastatic gastric cancer (KSCC1104)

Por Satake, Hironaga, Iwatsuki, Masaaki, Uenosono, Yoshikazu, Shiraishi, Takeshi, Tanioka, Hiroaki, Saeki, Hiroshi, Sugimachi, Keishi, Kitagawa, Dai, Shimokawa, Mototsugu, Oki, Eiji, Emi, Yasunori, Kakeji, Yoshihiro, Tsuji, Akihito, Akagi, Yoshito, Natsugoe, Shoji, Baba, Hideo, Maehara, Yoshihiko
Publicado no Cancer Chemother Pharmacol (2016)

Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004)

Por Toyoda, Masanori, Ajiki, Tetsuo, Fujiwara, Yutaka, Nagano, Hiroaki, Kobayashi, Shogo, Sakai, Daisuke, Hatano, Etsuro, Kanai, Masashi, Nakamori, Shoji, Miyamoto, Atsushi, Tsuji, Akihito, Kaihara, Satoshi, Ikoma, Hisashi, Takemura, Shigekazu, Toyokawa, Hideyoshi, Terajima, Hiroaki, Morita, Satoshi, Ioka, Tatsuya
Publicado em 2014

Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START)

Por Koizumi, Wasaburo, Kim, Yeul Hong, Fujii, Masashi, Kim, Hoon Kyo, Imamura, Hiroshi, Lee, Kyung Hee, Hara, Takuo, Chung, Hyun Cheol, Satoh, Taroh, Cho, Jae Yong, Hosaka, Hisashi, Tsuji, Akihito, Takagane, Akinori, Inokuchi, Mikito, Tanabe, Kazuaki, Okuno, Tatsuya, Ogura, Mariko, Yoshida, Kazuhiro, Takeuchi, Masahiro, Nakajima, Toshifusa
Publicado em 2013

Combined assessment of EGFR-related molecules to predict outcome of 1st-line cetuximab-containing chemotherapy for metastatic colorectal cancer

Por Sunakawa, Yu, Yang, Dongyun, Moran, Miriana, Astrow, Stephanie H., Tsuji, Akihito, Stephens, Craig, Zhang, Wu, Cao, Shu, Takahashi, Takehiro, Denda, Tadamichi, Shimada, Ken, Kochi, Mitsugu, Nakamura, Masato, Kotaka, Masahito, Segawa, Yoshihiko, Masuishi, Toshiki, Takeuchi, Masahiro, Fujii, Masashi, Nakajima, Toshifusa, Ichikawa, Wataru, Lenz, Heinz-Josef
Publicado no Cancer Biol Ther (2016)